Intralesional Tetracycline Injection in the Treatment of Chalazia

Withdrawn before enrolling · Early Phase 1

Conditions studied: Chalazia, Chalazion

In brief

The investigators propose a study to investigate the role of tetracycline injection into chalazia versus observation alone. The investigators hypothesize tetracycline injection will result in a significant decrease in lesion size when compared to observation alone.

Key facts

Study ID

NCT01763437

Run by

The Cleveland Clinic

People needed

0

Starts

2014-03-01

Expected to finish

2015-03-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age older than 18 years
• Not pregnant
• Chalazia of greater than 1 week duration
• Not allergic to tetracycline or its derivatives
• Not currently taking tetracycline or not taking them in the past 3 months

You may not qualify if…

• Age less than 18 years old
• Pregnancy
• Chalazia of less than 1 week duration
• Allergies to tetracycline or its derivatives
• Currently taking tetracyclines or have taken them in the past 3 months

Where it is running

• Cleveland Clinic Cole Eye Institute — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.